Outsourcing scene turns hotter
Indian pharmaceutical companies continue to move to the center stage of the global pharmaceutical market. There is a worldwide structural trend evolving in pharmaceuticals and Indian companies play a key role in this framework
CRAMS opens new vistas in partnering
The contract research and manufacturing services (CRAMS) has emerged as a new arena for the thriving Indian pharmaceutical industry to accelerate its overall growth prospects.
Dr Reddy's --- A partner of choice
The Hyderabad-based Dr. Reddy's has under its Custom Pharmaceutical Services (CPS) division established a strong foothold in contract research and manufacturing field by offering services at speed, efficiency and lower capital expenditures.
Shasun in CRAMS sunshine
The Indian pharmaceutical industry has come a long way from its crude incipient days and established its mark in the global market with mergers, acquisitions, joint ventures, exports and low cost outsourcing and contract services.
"MNCs start innovative research with Indian partners"
Advinus Therapeutics, promoted by the Tatas, focuses on new drug discovery and development of pharmaceutical and agrochemical products. Advinus has set its sight on pharmaceutical R&D with no generics or API focus.
Midcaps get high on CRAMS
Contract Research and Manufacturing Services (CRAMS) is a multibillion-dollar opportunity for Indian pharmaceutical companies possessing mandatory competence.
Syngene - Leveraging low-cost research
Syngene International, one of the subsidiaries of Biocon, said it has entered into a partnership with Bristol Myers Squibb (BMS) and Innate Pharmaceuticals, Sweden, to provide advanced and cost-effective research services.
Intas zooms in on bio ingredients
The Ahmedabad-based Intas Biopharmaceuticals Ltd said the company is set to tap emerging opportunities in active biologics ingredient (ABI) and biogenerics.
India: A vibrant location
It is felt that India is in a transition period. The country has already witnessed its transformation into an information technology (IT) super power.
Reliance Life broadens clinical services
Reliance Life Sciences (RLS), which has recently expanded its clinical research services to the US, is looking for acquisition in the developed markets with a view to broaden clinical research services.
Move to withdraw excise relief may hit manufacturing
The drug manufacturers in the excise free zones of Himachal Pradesh and Uttarakhand are up in arms against the central government's move to withdraw excise relief to the contract manufacturers in the excise free zones.
Copyright © Saffron Media Pvt. Ltd.